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Streptococcus suis infection is an emerging zoonosis in Asia. The most common disease manifestation is meningitis, which is often 
associated with hearing loss and cochleovestibular signs. S. suis infection in humans mainly occurs among risk groups that have 
frequent exposure to pigs or raw pork. Here, we report a case of S. suis meningitis in a 67-yr-old pig carcass handler, who presented 
with dizziness and sensorineural hearing loss followed by headaches. Gram-positive diplococci were isolated from cerebrospinal 
fluid (CSF) and blood cultures and showed gray-white colonies with α-hemolysis. S. suis was identified from CSF and blood cultures 
by using a Vitek 2 system (bioMérieux, France), API 20 STREP (bioMérieux), and performing 16S rRNA and tuf gene sequencing. 
Even after receiving antibiotic treatment, patients with S. suis infection frequently show complications such as hearing impairment 
and vestibular dysfunction. To the best of our knowledge, this is the first case of S. suis meningitis in Korea. Prevention through 
public health surveillance is recommended, especially for individuals who have occupational exposures to swine and raw pork.
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INTRODUCTION
Streptococcus suis is an important swine pathogen associ-
ated with a wide range of diseases in pigs. The upper respira-
tory tract, genital, and alimentary tracts are the natural habi-
tats of the pathogen in pigs [1]. S. suis is mainly transmitted 
to human beings by cutaneous contact with infected pigs or 
raw pork, especially when the skin has cuts and abrasions 
[2]. Human infection presents predominantly as acute men-
ingitis or arthritis, but may also present with pneumonia, 
endophthalmitis, endocarditis, and fatal septicemia. Patients 
with S. suis meningitis can develop permanent hearing loss 
[1, 3, 4]. Since the first human case was reported in Den-
mark in 1968, over 700 cases have been reported worldwide; 
most are from the European and Asian countries [2, 5]. 
Here, we report the first case of S. suis meningitis in Korea. 
CASE REPORT
Sixty seven-year-old man, working as a pig carcass han-
dler, present-ed with hearing difficulty and dizziness fol-
lowed by nausea and headache for 5 days. He had a history 
of hypertension and diabetes mellitus. On admission, his 
temperature was 35.1˚C, blood pressure was 86/65 mm Hg, 
pulse rate was at 61 beats per min, and respiratory rate was 
19 breaths per min. Although he was alert and oriented, 
physical examination revealed neck stiffness and limb and 
gait ataxia. Laboratory investigation showed a leukocyte 
count of 10,190/mm
3 with 90% polymorphonuclear cells 
and a platelet count of 87,000/mm
3. The serum C-reactive 
protein level (30.0 mg/dL) and erythrocyte sedimentation 
rate (45 mm/hr) were elevated. The coagulation proﬁle 
showed a slightly prolonged prothrombin time (15.5 sec, in-
ternational normalized ratio 1.22) and elevated D-dimer 
levels (11.53 µg/mL). The serum glucose level was 257 mg/
dL, and the serum creatinine level had increased to 1.69 mg/
dL. The patient’s cerebrospinal fluid (CSF) was turbid and 
had 2,350 leukocytes/μL (polymorphonuclear cells, 81%), 
he had a protein concentration of 349.9 mg/dL, and a glu-206     www.kjlm.org
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cose concentration of 10 mg/dL (serum glucose level of 257 
mg/dL). Therefore, bacterial meningitis was immediately 
suspected. After performing CSF analysis and 2 sets of pe-
ripheral blood cultur-es, empirical antibiotic treatment with 
intravenous ampicillin, ceftriaxone, and vancomycin was 
initiated. 
Computed tomographic (CT) scans of the head and tem-
poral bone showed normal results. However, magnetic res-
onance imaging (MRI) of the brain showed abnormal en-
hancement of the leptomeninges in both the cerebral hemi-
spheres (Fig. 1). Pure-tone audiometry showed profound 
bilateral sensorineural hearing loss. 
On day 2 at the hospital, aerobic bottles of both blood cul-
ture sets grew gram-positive diplococci after 8 hr of incuba-
tion in the BacT/Alert 3D system (bioMérieux Inc; Durham, 
NC, USA). CSF samples cultured in the thioglycollate broth 
also grew the same organisms (Fig. 2). Subinoculation on 
sheep blood agar plates was performed for both the CSF and 
blood cultures. After 24 hr of incubation at 35˚C in the pres-
ence of 5% CO2, we observed small gray-white colonies that 
showed catalase negativity, optochin resistance, and α-he-
molytic activity. After prolonged incubation for 48 hr, large 
colonies were visible and the α-hemolysis was more pro-
nounced (Fig. 3). This organism was identified as S. suis bio-
type II using the Vitek 2 Gram-Positive Identification (GPI) 
card (probability, 99.0%; which represents excellent identifi-
cation [ID]); (bioMérieux; Marcy-l’Etoile, France) and the 
API 20 STREP (profile code 4771473, % ID 99.7%, T index 
A B
Fig. 1. Brain MRIs. T1 weighted gadolinium enhanced axial (A) and coronal (B) images reveal diffuse leptomeningeal enhancement in both cerebral hemispheres.
Fig. 2. Gram stain of Streptococcus suis of cerebrospinal fluid showed Gram 
positive diplococci under a light microscope (×1,000).
Fig. 3. Gray-whitish, α-hemolytic colonies of Streptococcus suis on sheep 
blood agar plate at 35˚C in the presence of 5% CO2 after 24 hr incubation. Huh HJ, et al.  •  Streptococcus suis Meningitis with Hearing Loss
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Fig. 4. Molecular phylogenetic tree constructed by neighbor-joining method using the 16s rRNA (A) and tuf gene (B) sequences of our S. suis isolate and various 
Streptococcus species. Reference sequences were from the type strains of the species and accession numbers are given in parentheses. All names and accession 
numbers are given as cited in the GenBank database.   (Continued to the next page)
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0.73; bioMérieux). 
We performed 16S rRNA gene sequencing for the CSF 
isolate. The 16S rRNA gene fragments were amplified by 
standard methods according to CLSI guidelines [6]. Two 
subregions of the 16S rRNA gene were amplified using the 
following primer pairs: forward, 4F: 5´-TTG GAG AGT 
TTG ATC CTG GCT C-3´ and reverse, 534R: 5´-TAC CGC 
GGC TGC TGG CAC-3´ and forward, 27F: 5´-AGA GTT 
TGA TCM TGG CTC AG-3´ and reverse, 801R: 5´-GGC 
GTG GAC TTC CAG GGT ATC T-3´. The tuf gene frag-
ments were amplified with the forward (55C-F: 5´-GCC 
AGT TGA GGA CGT ATT CT-3´) and reverse (55C-R: 5´-
CCA TTT CAG TAC CTT CTG GTA A-3´) primers. Puri-
fied PCR products were sequenced directly by using the 
BigDye Terminator Cycle Sequencing Kit 3.1 (Applied Bio-
systems; Foster City, CA, USA) on an ABI Prism 3100 ge-
Fig. 4. (Continued from the previous page) Molecular phylogenetic tree constructed by neighbor-joining method using the 16s rRNA (A) and tuf gene (B) sequences of 
our S. suis isolate and various Streptococcus species. Reference sequences were from the type strains of the species and accession numbers are given in parenthe-
ses. All names and accession numbers are given as cited in the GenBank database. 
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netic analyzer (Applied Biosystems). A GenBank BLAST 
(The Basic Local Alignment Search Tool) search revealed 
that 16S rRNA gene and tuf gene sequences of the isolate 
show 100% (664/664 bp) and 99% (407/409 bp) homology 
with the corresponding sequences of a previously sequenc-
ed S. suis strain, respectively (GenBank accession number, 
CP000837.1). For further phylogenetic analysis, the CSF 
isolate 16S rRNA and tuf gene sequences were aligned using 
ClustalW [7]. Phylogenetic trees (Fig. 4) were constructed 
using the neighbor-joining method by using the MEGA 5 
software package (http://www.megasoftware.net) and Kim-
ura two parameters as the substitution model [8-10]. The 
statistical significance of the phylogenies was assessed by 
bootstrap analysis with 1,000 pseudoreplicate datasets. The 
tree is drawn to scale, with branch lengths in the same units 
as those of the evolutionary distances used to infer the phy-
logenetic tree. 
Antibiotic susceptibility tests were performed using the 
MicroScan MICroSTREP plus panel (Dade Behring; West 
Sacramento, CA, USA). The CSF isolate was susceptible to 
all the antimicrobial agents tested (penicillin, ampicillin, ce-
fotaxime, ceftriaxone, cefepime, meropenem, vancomycin, 
and chloramphenicol). On the basis of the results of suscep-
tibility test, the patient’s antibiotic therapy was changed to 
intravenous penicillin G (24 million units over 24 hr). 
Although the patient’s headache gradually improved, he 
experienced continued dizziness, bilateral hearing loss, and 
showed symptoms of vestibular dysfunction. On day 16 at 
the hospital, an MRI of the internal auditory canal revealed 
abnormal enhancement of the vestibular cochlea on both 
sides, which was suggestive of bilateral labyrinthitis. On day 
22 at the hospital, the patient was discharged and referred 
to a local hospital close to his home. Because the patient re-
quested outpatient treatment, the parenteral antibiotic ther-
apy was modified to once-daily dose of ceftriaxone (2 g ev-
ery 24 hr), as an alternative to 6 times-a-day administration 
of penicillin G.
After completing a 4-week course of parenteral antibiotic 
therapy, the patient continued to experience dizziness, hear-
ing difficulty, and headache during the 5-week follow-up. It 
was subsequently determined that the patient had sustained 
a hand abrasion a week before disease presentation and con-
tinued to handle pig carcasses at work without any protec-
tion, such as wearing gloves. 
DISCUSSION
S. suis is a gram-positive facultative anaerobe, which is 
coccoid or ovoid in shape and occurs as single cells, in pairs, 
or in short chains. On the basis of the capsular polysaccha-
rides, 35 serotypes of S. suis have been identified. Although 
the serotype was not identified in this case, serotype 2 is 
most commonly associated with diseases in pigs and human 
beings and is the most frequently reported serotype world-
wide [1, 11, 12]. Most S. suis strains produce narrow zones 
of α-hemolysis on sheep blood agar plates. S. suis serotype 2 
colonies show α- and β-hemolysis on sheep and horse blood 
agar plates, respectively [13]. Because the growth of S. suis 
on sheep blood agar plates is commonly used to identify the 
species in routine diagnostic laboratories, this species may 
be mistaken for viridans streptococci. Although bacterio-
logical diagnosis was made using commercial identification 
systems in this case, S. suis infections are often misidentified, 
or may remain undiagnosed [2]. S. suis is commonly mis-
identified and reported as Streptococcus species, α-hemolytic 
or viridans streptococci, Enterococcus faecalis, Aerococcus 
viridans, or even Streptococcus pneumoniae [2, 14]. An S. 
suis infection should be considered in regions with pig-
farming industries or in patients who are in contact with 
pigs or raw pork, if optochin-resistant Streptococcus are cul-
tured from a CSF sample obtained from a patient with men-
ingitis. Further microbiological investigations are required 
for the identification of α-hemolytic streptococci other than 
S. pneumoniae. 
Molecular techniques with PCR have improved the rate 
of detection of S. suis. The 16S RNA gene sequencing tech-
nique is a useful and definitive method for most Streptococ-
cus spp. For certain genera or groups of microorganisms, 
the use of alternative gene targets such as the tuf gene is 
necessary, because some species may share 99% to 100% 
16S rRNA sequence identity [6]. Thus, 16S rRNA and tuf 
gene sequencing were performed in this case. In phyloge-
netic analysis, the CSF isolate presented here was homolo-
gous with S. suis type strains based on 16S rRNA (GenBank 
accession number, AF009477.1) and tuf gene sequencing 
(AF274744.1), respectively (Fig. 4). Serotype-specific PCR 
assays and serological tests can be useful tools for the iden-
tification of S. suis serotypes [1, 15, 16]. Some commercial 
biochemical identification systems also report the biotype 
of S. suis (biotype I or II) [2]. Wertheim et al. suggested that 
the S. suis biotype should not be mistaken for serotype 1 or 
2, as was done in some previous reports [2, 17, 18].
S. suis infections have been reported worldwide. How-
ever, the majority of human cases have occurred in Asia 
(China, Thailand, Vietnam, and Japan) [1, 2, 19]. S. suis in-
fections in humans rarely occur in Korea. To date, only one 
S. suis infection in humans has been reported in Korea [20]. 
However, the possibility of undiagnosed S. suis infections 210     www.kjlm.org
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cannot be excluded. Although most reports of S. suis infec-
tions are sporadic cases, outbreaks of human S. suis infec-
tions are infrequently reported. Of note, the 2005 outbreak 
that occurred in Sichuan Province, China, involved 215 
cases and caused 38 deaths, emphasizing the importance of 
S. suis as an emerging zoonosis [21]. 
S. suis infections in humans are most often reported from 
countries where pig rearing is common, and the people who 
are in daily contact with pigs are usually affected. The rela-
tively high mean-patient age, the almost complete absence 
of children in the case series, and the high male-to-female 
patient ratio support the notion that S. suis infection is prin-
cipally an occupational disease [2, 4, 21-23]. In our case, the 
patient was exposed to S. suis through infected tissues of pig 
carcasses, which were handled without proper protection, 
such as gloves. Besides occupational exposure, processing 
or consuming uncooked or partially cooked pork products 
is also a risk factor for infection [2, 22-24]. Patients are gen-
erally healthy prior to infection with S. suis, although pre-
disposing factors, such as diabetes mellitus, alcoholism, and 
malignancy have been reported [25]. 
S. suis infection is typically manifested as meningitis. One 
remarkable symptom of S. suis meningitis is sensorineural 
hearing loss, which may be reported by up to half of the pa-
tients either at presentation or a few days later. This hearing 
loss is often bilateral, profound, and permanent [3, 22]. De-
afness with or without vestibular dysfunction is thought to 
be attributed to direct infection of the cochlea. S. suis is be-
lieved to enter the perilymph via the cochlear aqueduct 
through the lytic action of exotoxins [3]. Patients with S. 
suis meningitis may also show permanent incapacitation by 
vertigo and gait instability because of vestibular dysfunc-
tion. Such patients should immediately receive vestibular 
rehabilitation to improve their independence in daily activi-
ties [3, 26]. 
Analogous to protocols for any case of with suspected 
bacterial meningitis, immediate antibiotic administration is 
the first step in the treatment of bacterial meningitis. For 
empirical treatment, ceftriaxone with vancomycin (the same 
treatment dose and duration that is used for pneumococcal 
meningitis) is a good choice until the diagnosis is confirm-
ed. S. suis is sensitive to many antibiotics [1, 2]. Thus, once S. 
suis is verified as an infectious agent, antibiotic treatment 
accompanied with other associated treatments is very effec-
tive. After the confirmation of the presence of an S. suis in-
fection, patients are generally treated with penicillin G, ac-
companied by one or more other antibiotics including cef-
triaxone, gentamicin, chloramphenicol, and ampicillin. 
Penicillin G (24 million units over 24 hr for at least 10 days) 
or ceftriaxone (2 g every 12 hr for at least 10 days) has been 
used successfully for the treatment of S. suis meningitis. Re-
lapse of S. suis meningitis has been reported after 2 weeks of 
treatment with penicillin or ceftriaxone. However, the pa-
tients responded to a prolonged antibiotic treatment for 4-6 
weeks [1, 2, 23, 27]. The use of dexamethasone as an adjun-
ctive treatment to reduce mortality and improve the out-
come of bacterial meningitis remains controversial [28]. 
Quick diagnosis and early antibiotic treatment are the most 
important factors in decreasing the damage caused by S. 
suis infection. Therefore, in patients presenting with menin-
gitis, if characteristic features such as prominent and early 
hearing loss are observed, S. suis should be considered re-
gardless of the patient’s occupational background. 
Currently, there is no human S. suis vaccine. Therefore, 
prevention of transmission to humans depends on the con-
trol of spread of S. suis from infected pigs. Improvement of 
pig-raising conditions and pig vaccination are both effective 
methods to reduce the risk of human infection. Further-
more, increasing awareness of the disease by educating 
high-risk populations is also expected to help avoid human 
infection. Individuals with open wounds should wear gloves 
when handling raw or uncooked pork, and anyone who 
prepares pork should wash his or her hands and clean all 
the utensils thoroughly after contact [1, 29]. 
To the best of our knowledge, this is the first report of S. 
suis meningitis in humans in Korea. This case should re-
mind clinicians that S. suis meningitis affects people who 
are in daily contact with pigs. During diagnosis, S. suis in-
fection should not be confused with infections caused by 
other Streptococcus species. Prevention through public he-
alth surveillance is needed, and people with occupational 
exposures to swine and/or pork products should be edu-
cated. Increased awareness among both clinicians and mi-
crobiologists is required to fully appreciate the importance 
of S. suis infection as an emerging zoonosis and to promote 
early diagnosis and prevention of sequelae. 
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